rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
1999-3-5
|
pubmed:abstractText |
Autoantibodies against synthetic peptides of beta-adrenergic receptors have been observed in human cardiomyopathy. However, it has never been shown that such antibodies really interact with native human beta-adrenergic receptors, nor has the clinical impact of such an interaction been investigated in larger groups of patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0009-7322
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
9
|
pubmed:volume |
99
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
649-54
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9950662-Antigen-Antibody Reactions,
pubmed-meshheading:9950662-Autoantibodies,
pubmed-meshheading:9950662-Cardiac Output, Low,
pubmed-meshheading:9950662-Case-Control Studies,
pubmed-meshheading:9950662-Chronic Disease,
pubmed-meshheading:9950662-Female,
pubmed-meshheading:9950662-Heart,
pubmed-meshheading:9950662-Humans,
pubmed-meshheading:9950662-Male,
pubmed-meshheading:9950662-Middle Aged,
pubmed-meshheading:9950662-Receptors, Adrenergic, beta-1,
pubmed-meshheading:9950662-Recombinant Proteins,
pubmed-meshheading:9950662-Ventricular Function, Left
|
pubmed:year |
1999
|
pubmed:articleTitle |
Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure.
|
pubmed:affiliation |
Medizinische Poliklinik, Institut für Pharmakologie, University of Würzburg, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|